Dr. Hiteshi Dhami Shah is a highly qualified clinical nutritionist with a strong blend of clinical and research expertise in liver diseases and metabolic health. She has worked with leading hepatology and metabolic care centres and is actively involved in academic research, scientific writing, and patient-focused nutrition therapy. Her work integrates advanced nutritional science with practical clinical outcomes.
Educational Qualifications
- Post-doctoral Fellowship – Cell & Tissue Engineering, IIT Bombay
- Ph.D. – Food Science & Nutrition, SNDT University
- M.Sc. – Clinical Nutrition & Dietetics, Pune University
Professional Experience
- Consultant – Department of Hepatology & Intensive Liver Care Unit, Gleneagles Hospitals, Mumbai
- Consultant – Division of Endocrine & Metabolic Disorders, Kasturba Health Society Medical Research Centre
- Consultant – Parin Clinic
- Nutrition Writer – Stay Fit, Times Wellness
Professional Memberships
- Indian Dietetic Association (IDA)
- Indian Association for the Study of Liver Diseases (INASL)
Awards & Achievements
- Elected for SHARP (Sharpening Aptitude for Hepatology Research Program) by Stravitz-Sanyal Institute-VCU, JCMLRI, Liver Foundation West Bengal and INASL.
- Best Oral Presentation: "Hepatic Triad in 3D: Investigating Liver Function using Spheroid Culture to Establish Fatty Liver Conditions" – ISNN
- Poster Presentation Awards:
- "Hepatic Triad in 3D: Studying Liver Functionality through Spheroid Culture for Establishing Fatty Liver" – INASL
- "Picroside II reduces FFAs-induced lipid accumulation and lipotoxicity in an in vitro model of NAFLD" – EASL
- "Picroside II reduces lipid accumulation, oxidative stress and mitochondrial dysfunction in in vitro NAFLD model" – INASL
- "Simulation of an in vitro NAFLD model showed inhibition of lipid accumulation and lipotoxicity by Picroside II" – ICOCD
- Young Investigator Awards:
- "Identification of High-Risk Sarcopenia Phenotypes in ESLD and their Association with 1-year Post Transplant Mortality" – INASL
- "Picroside II reduces FFAs-induced lipid accumulation and lipotoxicity in an in vitro model of NAFLD" – EASL
- Women Scientist Fellowship & Grant, Department of Science and Technology, Government of India
.png)
.png)